Novozymes Increases Expectation For Full-Year Profit After Strong 3QDate Posted: October 23, 2014 Copenhagen, Denmark—October 23, 2014—Novozymes, the world’s largest producer of industrial enzymes, today announced its 2014 third quarter results. Organic sales increased by 8% compared with the first nine months 2013. EBIT grew by 16%, and the EBIT margin was 27.4%, when compared with the first nine months of 2013. Approximately half of the EBIT margin is due to the one-time positive impact from The BioAg Alliance, and the other half due to improved underlying earnings. As a result, expectations for full-year EBIT growth, EBIT margin, net profit growth, ROIC and free cash flow have increased. “We continue to see a good development in our business nine months into the year, and we increase the outlook for profit and cash flow for the full year,” says Novozymes’ CEO Peder Holk Nielsen. “Innovation has been a key driver of top and bottom line, and recent currency developments are contributing positively to the outlook. Sales have been in line with expectations, and we narrow in the outlook for organic sales growth to the middle of the range." "Uncertainties remain in a number of markets and in the macro environment, but our strong and diversified portfolio is broadly positioned for growth, and that is expected to prove valuable yet again.” Novozymes’ executive leadership team will present the results at a conference call today at 12.00 pm CET: http://www.novozymes.com/en/investor/events-presentations/Pages/conference-call.aspx The entire earnings report can be downloaded at news.novozymes.com. For more information, please contact Paige Donnelly at 1-919-494-3209 or pagd@novozymes.com Ethanol
|
|
©2001-2014 Country Journal Publishing Co.
3065 Pershing Ct. • Decatur, IL 62526 • 800-728-7511 • 217-877-9660 • Email: webmaster@grainnet.com
No portion of this site may be copied or reproduced without prior express
written permission.
